Longer-term experience with tenofovir alafenamide (TAF) in HBV-infected patients; changes in EGFR, FIB4, ALT, and DNA suppression Reddy, R., Curry, M., Dieterich, D., Ankoma-Sey, V., Pan, C., Hann, H., Tong, M., Kim, W., Kwo, P., Frazier, L., Cox, K., Milligan, S., Afdhal, N. ELSEVIER. 2020: S881-S882

View details for Web of Science ID 000786587002534